Forecasts by Source (Mammalian, Non-mammalian), by Service (Process Development, Fill & Finish Operations, Analytical & QC Studies, Packaging), by Product (Biologics, Biosimilars), by Company Size (Small, Mid-sized, Large), by Scale of Operations (Preclinical, Clinical, Commercial) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis
The Biopharmaceuticals Contract Manufacturing Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Every year, new and unique drug products and technologies come out. This changes the way biopharma works and what kinds of treatments are possible. This is partly because outsourcing gives them the ability and freedom to do so. Emerging and virtual companies that are driving the future pipeline depend heavily on external development partners, and not just for hard-to-make products. Even more well-known companies are signing contracts with CDMOs to get access to their resources and certain skills. In cell and gene therapy (CGT), many of the chemistry, manufacturing, and control (CMC) jobs, such as process development, analytical development, testing, manufacturing, and filling and finishing, are done by outside companies. Outsourcing can happen at almost any point in the life cycle of a treatment, all the way up until it goes on the market.
CGTs have problems that require expensive and hard-to-find consumables, tools, space, and talent. This could lead a company to think about outsourcing clinical through commercial manufacturing processes. Big companies have the means to develop and make products, but they may need help with certain tasks, such as specialised analytical assays or studies to improve the way a process works. Small companies, which make up most of the advanced biotherapeutic developers right now, don’t have a lot of internal development and manufacturing capacity or experience, so they tend to outsource process development, process scaling up, and manufacturing.
What Questions Should You Ask before Buying a Market Research Report? • How is the biopharmaceuticals contract manufacturing market evolving? • What is driving and restraining the biopharmaceuticals contract manufacturing market? • How will each biopharmaceuticals contract manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033? • How will the market shares for each biopharmaceuticals contract manufacturing submarket develop from 2023 to 2033? • What will be the main driver for the overall market from 2023 to 2033? • Will leading biopharmaceuticals contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033? • Who are the leading players and what are their prospects over the forecast period? • What are the biopharmaceuticals contract manufacturing projects for these leading companies? • How will the industry evolve during the period between 2023 and 2033? What are the implications of biopharmaceuticals contract manufacturing projects taking place now and over the next 10 years? • Is there a greater need for product commercialisation to further scale the biopharmaceuticals contract manufacturing market? • Where is the biopharmaceuticals contract manufacturing market heading and how can you ensure you are at the forefront of the market? • What are the best investment options for new product and service lines? • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the biopharmaceuticals contract manufacturing market today, and over the next 10 years: • Our 358-page report provides 140 tables and 167 charts/graphs exclusively to you. • The report highlights key lucrative areas in the industry so you can target them – NOW. • It contains in-depth analysis of global, regional and national sales and growth. • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the biopharmaceuticals contract manufacturing market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares. • You will find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Source • Mammalian • Non-mammalian
Service • Process Development • Fill & Finish Operations • Analytical & QC Studies • Packaging
Product • Biologics • Biosimilars
Company Size • Small • Mid-sized • Large
Scale of Operations • Preclinical • Clinical • Commercial
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 23 leading national markets:
North America • U.S. • Canada
Europe • Germany • UK • France • Italy • Spain • Russia • Rest of Europe
Asia Pacific • Japan • China • India • Australia • South-East Asia • Rest of Asia Pacific
Latin America • Brazil • Mexico • Argentina • Colombia • Rest of Latin America
The report also includes profiles and for some of the leading companies in the Biopharmaceuticals Contract Manufacturing Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth • AbbVie, Inc. • AGC Biologics • Avantor, Inc. • Binex Co., Ltd. • Boehringer Ingelheim GmbH • Cambrex Corporation • Catalent Inc • Curia Global, Inc. • Cytiva • FUJIFILM Diosynth Biotechnologies • JRS PHARMA • Jubilant Pharma Limited • KBI Biopharma • Lonza • Pfizer CentreOne • ProBioGen • Rentschler Biopharma SE • Samsung Biologics • Sandoz • TOYOBO CO., LTD. • Thermo Fisher Scientific • WuXi Biologics
Overall world revenue for Biopharmaceuticals Contract Manufacturing Market, 2023 to 2033 in terms of value the market will surpass US$15,280.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Biopharmaceuticals Contract Manufacturing Market, 2023 to 2033 report help you? In summary, our 350+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Biopharmaceuticals Contract Manufacturing Market, 2023 to 2033 Market, with forecasts for Source, service, product, company size, and scale of operations, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 23 key national markets – See forecasts for the Biopharmaceuticals Contract Manufacturing Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 22 of the major companies involved in the Biopharmaceuticals Contract Manufacturing Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Biopharmaceuticals Contract Manufacturing Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Buy our report today Biopharmaceuticals Contract Manufacturing Market Report 2023-2033: Forecasts by Source (Mammalian, Non-mammalian), by Service (Process Development, Fill & Finish Operations, Analytical & QC Studies, Packaging), by Product (Biologics, Biosimilars), by Company Size (Small, Mid-sized, Large), by Scale of Operations (Preclinical, Clinical, Commercial) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview 1.1 Objectives of the Study 1.2 Introduction to Biopharmaceuticals Contract Manufacturing Market 1.3 What This Report Delivers 1.4 Why You Should Read This Report 1.5 Key Questions Answered by This Analytical Report Include: 1.6 Who is This Report For? 1.7 Methodology 1.7.1 Market Definitions 1.7.2 Market Evaluation & Forecasting Methodology 1.7.3 Data Validation 1.7.3.1 Primary Research 1.7.3.2 Secondary Research 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2 Executive Summary 2.1 Emerging Outsourcing Trends in Biopharmaceuticals 2.2 Demand for RNA-based COVID-19 Vaccines Creates Revenue Opportunities for Contact Manufacturers 2.3 Increase in Investment in Research & Development 2.4 Analyst Viewpoint
3 Market Overview 3.1 Key Findings 3.2 Market Dynamics 3.2.1 Market Driving Factors 3.2.1.1 Rise in Investment by CMOs for Capacity Expansion 3.2.1.2 Cost and Time Saving Benefits Offered by Contract Services 3.2.1.3 Outsourcing as a Driver for Market Growth 3.2.1.4 Growing Investments in Orphan Drugs 3.2.2 Market Restraining Factors 3.2.2.1 Pricing Pressure to Impede Market Growth 3.2.2.2 Regulatory Scenarios 3.2.2.3 Overcapacity Likely to Challenge Market Growth 3.2.3 Market Opportunities 3.2.3.1 Expansion of Fill and Finish CMOs 3.2.3.2 Emergence of Single-Use Bioprocessing Equipment & Solutions 3.2.3.3 Emerging Economies to Offer Lucrative Growth Opportunities 3.3 COVID-19 Impact Analysis 3.4 SWOT Analysis 3.4.1 Strengths 3.4.2 Weaknesses 3.4.3 Opportunities 3.4.4 Threats 3.5 Porter’s Five Forces Analysis 3.5.1 Buyer Power 3.5.2 Supplier Power 3.5.3 Competitive Rivalry 3.5.4 Threat of Substitute 3.5.5 Threat of New Entrants 3.6 PEST Analysis 3.6.1 Political Factors Impacting Biopharmaceuticals Contract Manufacturing Market 3.6.2 Economic Factors Impacting Biopharmaceuticals Contract Manufacturing Market 3.6.3 Social Factors Impacting Biopharmaceuticals Contract Manufacturing Market 3.6.4 Technological Factors Impacting Biopharmaceuticals Contract Manufacturing Market
4 Biopharmaceuticals Contract Manufacturing Market Analysis by Source 4.1 Key Findings 4.2 Source Segment: Market Attractiveness Index 4.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source 4.4 Mammalian 4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn) 4.4.2 Market Share by Region, 2023 & 2033 (%) 4.5 Non-mammalian 4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn) 4.5.2 Market Share by Region, 2023 & 2033 (%)
5 Biopharmaceuticals Contract Manufacturing Market Analysis by Service 5.1 Key Findings 5.2 Service Segment: Market Attractiveness Index 5.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service 5.4 Process Development 5.4.1 Upstream Process Development 5.4.2 Downstream Process Development 5.4.3 Market Forecast by Region, 2023-2033 (US$ Mn) 5.4.4 Market Share by Region, 2023 & 2033 (%) 5.4.4.1 Market Forecast by Type, 2023-2033 (US$ Mn) 5.5 Fill & Finish Operations 5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn) 5.5.2 Market Share by Region, 2023 & 2033 (%) 5.6 Analytical & QC Studies 5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn) 5.6.2 Market Share by Region, 2023 & 2033 (%) 5.7 Packaging 5.7.1 Market Forecast by Region, 2023-2033 (US$ Mn) 5.7.2 Market Share by Region, 2023 & 2033 (%)
6 Biopharmaceuticals Contract Manufacturing Market Analysis by Product 6.1 Key Findings 6.2 Product Segment: Market Attractiveness Index 6.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product 6.4 Biologics 6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn) 6.4.2 Market Share by Region, 2023 & 2033 (%) 6.4.2.1 Market Forecast by Type, 2023-2033 (US$ Mn) 6.5 Biosimilars 6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn) 6.5.2 Market Share by Region, 2023 & 2033 (%)
7 Biopharmaceuticals Contract Manufacturing Market Analysis by Scale of Operation 7.1 Key Findings 7.2 Scale of Operation Segment: Market Attractiveness Index 7.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation 7.4 Preclinical 7.4.1 Market Forecast by Region, 2023-2033 (US$ Mn) 7.4.2 Market Share by Region, 2023 & 2033 (%) 7.5 Clinical 7.5.1 Market Forecast by Region, 2023-2033 (US$ Mn) 7.5.2 Market Share by Region, 2023 & 2033 (%) 7.6 Commercial 7.6.1 Market Forecast by Region, 2023-2033 (US$ Mn) 7.6.2 Market Share by Region, 2023 & 2033 (%)
8 Biopharmaceuticals Contract Manufacturing Market Analysis by Company Size 8.1 Key Findings 8.2 Company Size Segment: Market Attractiveness Index 8.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size 8.4 Small 8.4.1 Market Forecast by Region, 2023-2033 (US$ Mn) 8.4.2 Market Share by Region, 2023 & 2033 (%) 8.5 Mid-sized 8.5.1 Market Forecast by Region, 2023-2033 (US$ Mn) 8.5.2 Market Share by Region, 2023 & 2033 (%) 8.6 Large 8.6.1 Market Forecast by Region, 2023-2033 (US$ Mn) 8.6.2 Market Share by Region, 2023 & 2033 (%)
9 Biopharmaceuticals Contract Manufacturing Market Analysis by Region 9.1 Key Findings 9.2 Regional Market Size Estimation and Forecast
10 North America Biopharmaceuticals Contract Manufacturing Market Analysis 10.1 Key Findings 10.2 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index 10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn) 10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn) 10.5 Market Size Estimation and Forecast by Source, 2023-2033 (US$ Mn) 10.6 Market Size Estimation and Forecast by Service, 2023-2033 (US$ Mn) 10.7 Market Size Estimation and Forecast by Product, 2023-2033 (US$ Mn) 10.8 Market Size Estimation and Forecast by Scale of Operation, 2023-2033 (US$ Mn) 10.9 Market Size Estimation and Forecast by Company Size, 2023-2033 (US$ Mn) 10.10 U.S. Biopharmaceuticals Contract Manufacturing Market Analysis 10.11 Canada Biopharmaceuticals Contract Manufacturing Market Analysis
11 Europe Biopharmaceuticals Contract Manufacturing Market Analysis 11.1 Key Findings 11.2 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index 11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn) 11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn) 11.5 Market Size Estimation and Forecast by Source, 2023-2033 (US$ Mn) 11.6 Market Size Estimation and Forecast by Service, 2023-2033 (US$ Mn) 11.7 Market Size Estimation and Forecast by Product, 2023-2033 (US$ Mn) 11.8 Market Size Estimation and Forecast by Scale of Operation, 2023-2033 (US$ Mn) 11.9 Market Size Estimation and Forecast by Company Size, 2023-2033 (US$ Mn) 11.10 Germany Biopharmaceuticals Contract Manufacturing Market Analysis 11.11 UK Biopharmaceuticals Contract Manufacturing Market Analysis 11.12 France Biopharmaceuticals Contract Manufacturing Market Analysis 11.13 Italy Biopharmaceuticals Contract Manufacturing Market Analysis 11.13.1 Role of CDMO Business Across Italy 11.13.2 Investment by Major Players to Fuel Market Expansion 11.14 Spain Biopharmaceuticals Contract Manufacturing Market Analysis 11.15 Russia Biopharmaceuticals Contract Manufacturing Market Analysis 11.16 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Analysis
12 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis 12.1 Key Findings 12.2 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index 12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn) 12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn) 12.5 Market Size Estimation and Forecast by Source, 2023-2033 (US$ Mn) 12.6 Market Size Estimation and Forecast by Service, 2023-2033 (US$ Mn) 12.7 Market Size Estimation and Forecast by Product, 2023-2033 (US$ Mn) 12.8 Market Size Estimation and Forecast by Scale of Operation, 2023-2033 (US$ Mn) 12.9 Market Size Estimation and Forecast by Company Size, 2023-2033 (US$ Mn) 12.10 Japan Biopharmaceuticals Contract Manufacturing Market Analysis 12.11 China Biopharmaceuticals Contract Manufacturing Market Analysis 12.12 India Biopharmaceuticals Contract Manufacturing Market Analysis 12.12.1 The COVID-19 pandemic has brought India’s biotechnology industry, especially biopharmaceuticals into the limelight 12.12.2 Piramal Pharma Ltd. Invests Minority Stake in CDMO Yapan Bio 12.12.3 Stelis Biopharma Limited Receives EU-GMP for Two of its Manufacturing Facilities 12.13 Australia Biopharmaceuticals Contract Manufacturing Market Analysis 12.14 South-East Asia Biopharmaceuticals Contract Manufacturing Market Analysis 12.15 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis
13 Latin America Biopharmaceuticals Contract Manufacturing Market Analysis 13.1 Key Findings 13.2 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index 13.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn) 13.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn) 13.5 Market Size Estimation and Forecast by Source, 2023-2033 (US$ Mn) 13.6 Market Size Estimation and Forecast by Service, 2023-2033 (US$ Mn) 13.7 Market Size Estimation and Forecast by Product, 2023-2033 (US$ Mn) 13.8 Market Size Estimation and Forecast by Scale of Operation, 2023-2033 (US$ Mn) 13.9 Market Size Estimation and Forecast by Company Size, 2023-2033 (US$ Mn) 13.10 Brazil Biopharmaceuticals Contract Manufacturing Market Analysis 13.11 Mexico Biopharmaceuticals Contract Manufacturing Market Analysis 13.12 Argentina Biopharmaceuticals Contract Manufacturing Market Analysis 13.13 Colombia Biopharmaceuticals Contract Manufacturing Market Analysis 13.14 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Analysis
14 MEA Biopharmaceuticals Contract Manufacturing Market Analysis 14.1 Key Findings 14.2 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index 14.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn) 14.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn) 14.5 Market Size Estimation and Forecast by Source, 2023-2033 (US$ Mn) 14.6 Market Size Estimation and Forecast by Service, 2023-2033 (US$ Mn) 14.7 Market Size Estimation and Forecast by Product, 2023-2033 (US$ Mn) 14.8 Market Size Estimation and Forecast by Scale of Operation, 2023-2033 (US$ Mn) 14.9 Market Size Estimation and Forecast by Company Size, 2023-2033 (US$ Mn) 14.10 GCC Biopharmaceuticals Contract Manufacturing Market Analysis 14.11 South Africa Biopharmaceuticals Contract Manufacturing Market Analysis 14.12 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Analysis
15 Company Profiles 15.1 AbbVie, Inc. 15.1.1 Company Snapshot 15.1.2 Company Overview 15.1.3 Financial Analysis 15.1.3.1 Net Revenue, 2015-2022 15.1.3.2 R&D Expenses, 2015-2022 15.1.3.3 Regional Market Shares, 2022 15.1.4 Service Benchmarking 15.1.5 Strategic Outlook 15.2 AGC Biologics 15.2.1 Company Snapshot 15.2.2 Company Overview 15.2.3 Service Benchmarking 15.2.4 Strategic Outlook 15.3 Avantor, Inc. 15.3.1 Company Snapshot 15.3.2 Company Overview 15.3.3 Financial Analysis 15.3.3.1 Net Revenue, 2017-2022 15.3.3.2 Regional Market Shares, 2021 15.3.4 Service Benchmarking 15.3.5 Strategic Outlook 15.4 Binex Co., Ltd. 15.4.1 Company Snapshot 15.4.2 Company Overview 15.4.3 Service Benchmarking 15.5 Boehringer Ingelheim GmbH 15.5.1 Company Snapshot 15.5.2 Company Overview 15.5.3 Financial Analysis 15.5.3.1 Net Revenue, 2015-2021 15.5.4 Service Benchmarking 15.5.5 Strategic Outlook 15.6 FUJIFILM Diosynth Biotechnologies 15.6.1 Company Snapshot 15.6.2 Company Overview 15.6.3 Service Benchmarking 15.6.4 Strategic Outlook 15.7 Lonza 15.7.1 Company Snapshot 15.7.2 Company Overview 15.7.3 Financial Analysis 15.7.3.1 Net Revenue, 2015-2022 15.7.3.2 R&D Expenses, 2017-2021 15.7.4 Service Benchmarking 15.7.5 Strategic Outlook 15.8 ProBioGen 15.8.1 Company Snapshot 15.8.2 Company Overview 15.8.3 Service Benchmarking 15.8.4 Strategic Outlook 15.9 Rentschler Biopharma SE 15.9.1 Company Snapshot 15.9.2 Company Overview 15.9.3 Service Benchmarking 15.9.4 Strategic Outlook 15.10 Samsung Biologics 15.10.1 Company Snapshot 15.10.2 Company Overview 15.10.3 Service Benchmarking 15.10.4 Strategic Outlook 15.11 Sandoz 15.11.1 Company Snapshot 15.11.2 Company Overview 15.11.3 Financial Analysis 15.11.3.1 Net Revenue, 2015-2022 15.11.3.2 Regional Market Shares, 2021 15.11.4 Service Benchmarking 15.11.5 Strategic Outlook 15.12 TOYOBO CO., LTD. 15.12.1 Company Snapshot 15.12.2 Company Overview 15.12.3 Service Benchmarking 15.13 WuXi Biologics 15.13.1 Company Snapshot 15.13.2 Company Overview 15.13.3 Financial Analysis 15.13.3.1 Net Revenue, 2015-2022 15.13.3.2 Regional Market Shares, 2022 15.13.4 Service Benchmarking 15.13.5 Strategic Outlook 15.14 JRS PHARMA 15.14.1 Company Snapshot 15.14.2 Company Overview 15.14.3 Service Benchmarking 15.14.4 Strategic Outlook 15.15 Thermo Fisher Scientific 15.15.1 Company Snapshot 15.15.2 Company Overview 15.15.3 Financial Analysis 15.15.3.1 Net Revenue, 2015-2022 15.15.3.2 R&D, 2015-2022 15.15.3.3 Regional Market Shares, 2022 15.15.4 Service Benchmarking 15.16 Cambrex Corporation 15.16.1 Company Snapshot 15.16.2 Company Overview 15.16.3 Service Benchmarking 15.16.4 Strategic Outlook 15.17 Curia Global, Inc. 15.17.1 Company Snapshot 15.17.2 Company Overview 15.17.3 Service Benchmarking 15.17.4 Strategic Outlook 15.18 Pfizer CentreOne 15.18.1 Company Snapshot 15.18.2 Company Overview 15.18.3 Financial Analysis 15.18.3.1 Net Revenue, 2015-2022 15.18.3.2 R&D, 2015-2022 15.18.3.3 Regional Market Shares, 2022 15.18.4 Service Benchmarking 15.19 Jubilant Pharma Limited 15.19.1 Company Snapshot 15.19.2 Company Overview 15.19.3 Service Benchmarking 15.20 Catalent, Inc 15.20.1 Company Snapshot 15.20.2 Company Overview 15.20.3 Financial Analysis 15.20.3.1 Net Revenue, 2015-2022 15.20.4 Service Benchmarking 15.20.5 Strategic Outlook 15.21 KBI Biopharma 15.21.1 Company Snapshot 15.21.2 Company Overview 15.21.3 Service Benchmarking 15.21.4 Strategic Outlook 15.22 Cytiva 15.22.1 Company Snapshot 15.22.2 Company Overview 15.22.3 Service Benchmarking 15.22.4 Strategic Outlook
16 Conclusion and Recommendations 16.1 Concluding Remarks from Visiongain 16.2 Recommendations for Market Players
List of Tables Table 1 Biopharmaceuticals Contract Manufacturing Market Snapshot, 2023 & 2033 (US$ million, CAGR %) Table 2 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery Table 3 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery Table 4 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery Table 5 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery Table 6 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%) Table 7 Mammalian Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 8 Non-mammalian Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 9 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%) Table 10 Process Development Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 11 Biopharmaceuticals Contract Manufacturing Market Forecast by Process Development, 2023-2033 (US$ mn, AGR%, CAGR%) Table 12 Fill & Finish Operations Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 13 Analytical & QC Studies Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 14 Packaging Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 15 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%) Table 16 Biologics Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 17 Biopharmaceuticals Contract Manufacturing Market Forecast by Application, 2023-2033 (US$ mn, AGR%, CAGR%) Table 18 Biosimilars Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 19 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 20 Clinical Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 21 Commercial Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 22 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%) Table 23 Small Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 24 Mid-sized Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 25 Large Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 26 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%) Table 27 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 28 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%) Table 29 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%) Table 30 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%) Table 31 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR%) Table 32 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%) Table 33 U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 34 Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 35 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 36 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%) Table 37 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%) Table 38 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%) Table 39 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR%) Table 40 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%) Table 41 Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 42 UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 43 France Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 44 Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 45 Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 46 Russia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 47 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 48 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 49 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%) Table 50 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%) Table 51 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%) Table 52 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR%) Table 53 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%) Table 54 Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 55 China Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 56 India Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 57 Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 58 South-East Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 59 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 60 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 61 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%) Table 62 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%) Table 63 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%) Table 64 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR%) Table 65 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%) Table 66 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 67 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 68 Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 69 Colombia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 70 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 71 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%) Table 72 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%) Table 73 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%) Table 74 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%) Table 75 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR%) Table 76 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%) Table 77 GCC Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 78 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 79 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%) Table 80 AbbVie, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 81 AbbVie, Inc.: Service Benchmarking Table 82 AbbVie, Inc.: Strategic Outlook Table 83 AGC Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 84 AGC Biologics: Service Benchmarking Table 85 AGC Biologics: Strategic Outlook Table 86 Avantor, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 87 Avantor, Inc.: Service Benchmarking Table 88 Avantor, Inc.: Strategic Outlook Table 89 Binex Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 90 Binex Co., Ltd.: Service Benchmarking Table 91 Boehringer Ingelheim GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 92 Boehringer Ingelheim GmbH: Service Benchmarking Table 93 Boehringer Ingelheim GmbH: Strategic Outlook Table 94 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 95 FUJIFILM Diosynth Biotechnologies: Service Benchmarking Table 96 FUJIFILM Diosynth Biotechnologies: Strategic Outlook Table 97 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 98 Lonza: Service Benchmarking Table 99 Lonza: Strategic Outlook Table 100 ProBioGen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 101 ProBioGen: Service Benchmarking Table 102 ProBioGen: Strategic Outlook Table 103 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 104 Rentschler Biopharma SE: Service Benchmarking Table 105 Rentschler Biopharma SE: Strategic Outlook Table 106 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 107 Samsung Biologics: Service Benchmarking Table 108 Samsung Biologics: Strategic Outlook Table 109 Sandoz: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 110 Sandoz: Service Benchmarking Table 111 Sandoz: Strategic Outlook Table 112 TOYOBO CO., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 113 TOYOBO CO., LTD.: Service Benchmarking Table 114 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 115 WuXi Biologics: Service Benchmarking Table 116 WuXi Biologics: Strategic Outlook Table 117 JRS PHARMA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 118 JRS PHARMA: Service Benchmarking Table 119 JRS PHARMA: Strategic Outlook Table 120 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 121 Thermo Fisher Scientific: Service Benchmarking Table 122 Cambrex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 123 Cambrex Corporation: Service Benchmarking Table 124 Cambrex Corporation: Strategic Outlook Table 125 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 126 Curia Global, Inc.: Service Benchmarking Table 127 Curia Global, Inc.: Strategic Outlook Table 128 Pfizer CentreOne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 129 Pfizer CentreOne: Service Benchmarking Table 130 Jubilant Pharma Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 131 Jubilant Pharma Limited: Service Benchmarking Table 132 Catalent, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 133 Catalent, Inc: Service Benchmarking Table 134 Catalent, Inc: Strategic Outlook Table 135 KBI Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 136 KBI Biopharma: Service Benchmarking Table 137 KBI Biopharma: Strategic Outlook Table 138 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 139 Cytiva: Service Benchmarking Table 140 Cytiva: Strategic Outlook
List of Figures Figure 1 Biopharmaceuticals Contract Manufacturing Market Segmentation Figure 2 Biopharmaceuticals Contract Manufacturing Market: Market Dynamics Figure 3 Biopharmaceuticals Contract Manufacturing Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery Figure 4 Biopharmaceuticals Contract Manufacturing Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery Figure 5 Biopharmaceuticals Contract Manufacturing Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery Figure 6 Biopharmaceuticals Contract Manufacturing Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery Figure 7 SWOT Analysis Figure 8 Porter’s Five Forces Analysis Figure 9 PEST Analysis Figure 10 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source Figure 11 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %) Figure 12 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023, 2028, 2033 (%) Figure 13 Mammalian Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 14 Mammalian Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 15 Non-mammalian Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 16 Non-mammalian Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 17 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source Figure 18 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %) Figure 19 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023, 2028, 2033 (%) Figure 20 Process Development Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 21 Process Development Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 22 Process Development Segment Market Forecast by Type, 2023-2033 (US$ Million, AGR %) Figure 23 Fill & Finish Operations Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 24 Fill & Finish Operations Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 25 Analytical & QC Studies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 26 Analytical & QC Studies Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 27 Packaging Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 28 Packaging Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 29 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Product Figure 30 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %) Figure 31 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023, 2028, 2033 (%) Figure 32 Biologics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 33 Biologics Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 34 Biologics Segment Market Forecast by Type, 2023-2033 (US$ Million, AGR %) Figure 35 Biosimilars Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 36 Biosimilars Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 37 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Scale of Operation Figure 38 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %) Figure 39 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023, 2028, 2033 (%) Figure 40 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 41 Preclinical Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 42 Clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 43 Clinical Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 44 Commercial Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 45 Commercial Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 46 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Company Size Figure 47 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 48 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023, 2028, 2033 (%) Figure 49 Small Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 50 Small Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 51 Mid-sized Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 52 Mid-sized Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 53 Large Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %) Figure 54 Large Segment Market Share Forecast by Region, 2023 & 2033 (%) Figure 55 Biopharmaceuticals Contract Manufacturing Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%) Figure 56 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Region 2023, 2028, 2033 (%) Figure 57 Biopharmaceuticals Contract Manufacturing Market by Region, 2023-2033 (US$ Mn) Figure 58 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index Figure 59 North America Biopharmaceuticals Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ million) Figure 60 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %) Figure 61 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%) Figure 62 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %) Figure 63 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023 & 2033 (%) Figure 64 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %) Figure 65 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023 & 2033 (%) Figure 66 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %) Figure 67 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023 & 2033 (%) Figure 68 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %) Figure 69 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%) Figure 70 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 71 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%) Figure 72 U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 73 Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %) Figure 74 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index Figure 75 Europe Biopharmaceuticals Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ million) Figure 76 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%) Figure 77 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %) Figure 78 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023 & 2033 (%) Figure 79 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %) Figure 80 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023 & 2033 (%) Figure 81 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %) Figure 82 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023 & 2033 (%) Figure 83 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %) Figure 84 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%) Figure 85 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 86 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%) Figure 87 Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 88 UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 89 France Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 90 Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 91 Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 92 Russia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 93 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 94 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index Figure 95 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ million) Figure 96 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %) Figure 97 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%) Figure 98 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %) Figure 99 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023 & 2033 (%) Figure 100 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %) Figure 101 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023 & 2033 (%) Figure 102 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %) Figure 103 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023 & 2033 (%) Figure 104 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %) Figure 105 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%) Figure 106 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 107 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%) Figure 108 Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 109 China Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 110 India Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 111 Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 112 South-East Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 113 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 114 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index Figure 115 Latin America Biopharmaceuticals Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ million) Figure 116 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%) Figure 117 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %) Figure 118 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023 & 2033 (%) Figure 119 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %) Figure 120 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023 & 2033 (%) Figure 121 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %) Figure 122 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023 & 2033 (%) Figure 123 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %) Figure 124 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%) Figure 125 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 126 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%) Figure 127 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 128 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 129 Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 130 Colombia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 131 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 132 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index Figure 133 MEA Biopharmaceuticals Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ million) Figure 134 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %) Figure 135 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%) Figure 136 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %) Figure 137 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023 & 2033 (%) Figure 138 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %) Figure 139 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023 & 2033 (%) Figure 140 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %) Figure 141 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023 & 2033 (%) Figure 142 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %) Figure 143 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%) Figure 144 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %) Figure 145 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%) Figure 146 GCC Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 147 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 148 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %) Figure 149 AbbVie, Inc.: Net Revenue, 2015-2022 (US$ million, AGR%) Figure 150 AbbVie, Inc.: R&D Expenses, 2015-2022 (US$ million, AGR%) Figure 151 AbbVie, Inc.: Regional Market Shares, 2022 (%) Figure 152 Avantor, Inc.: Net Revenue, 2017-2022 (US$ million, AGR%) Figure 153 Avantor, Inc.: Regional Market Share (AGR%) Figure 154 Boehringer Ingelheim GmbH: Net Revenue, 2015-2021 (US$ million, AGR%) Figure 155 Lonza: Net Revenue, 2015-2022 (US$ million, AGR%) Figure 156 Lonza: R&D Expenses, 2017-2021 (US$ million, AGR%) Figure 157 Sandoz: Net Revenue, 2015-2022 (US$ million, AGR%) Figure 158 Sandoz: Regional Market Share (AGR%) Figure 159 WuXi Biologics: Net Revenue, 2015-2022 (US$ million, AGR%) Figure 160 WuXi Biologics: Regional Market Shares, 2022 (%) Figure 161 Thermo Fisher Scientific: Net Revenue, 2015-2022 (US$ million, AGR%) Figure 162 Thermo Fisher Scientific: R&D, 2015-2022 (US$ million, AGR%) Figure 163 Thermo Fisher Scientific: Regional Market Shares, 2022 (%) Figure 164 Pfizer CentreOne: Net Revenue, 2015-2022 (US$ million, AGR%) Figure 165 Pfizer CentreOne: R&D, 2015-2022 (US$ million, AGR%) Figure 166 Pfizer CentreOne: Regional Market Shares, 2022 (%) Figure 167 Catalent, Inc: Net Revenue, 2015-2022 (US$ million, AGR%)
List of Companies Profiled in the Report AbbVie, Inc. AGC Biologics Avantor, Inc. Binex Co., Ltd. Boehringer Ingelheim GmbH Cambrex Corporation Catalent Inc Curia Global, Inc. Cytiva FUJIFILM Diosynth Biotechnologies JRS PHARMA Jubilant Pharma Limited KBI Biopharma Lonza Pfizer CentreOne ProBioGen Rentschler Biopharma SE Samsung Biologics Sandoz TOYOBO CO., LTD. Thermo Fisher Scientific WuXi Biologics
List of Other Companies Mentioned in the Report Agilent Technologies ALSA Ventures Atara Biotherapeutics, Inc. aTyr Pharma Asahi Kasei Pharma AstraZeneca Awakn Life Sciences Corp. Bacthera Bhami Research Laboratory Biogen Inc. BioGeneration Ventures Bioqube Ventures BlueJay Chimeron Bio Codiak BioSciences Cytovance Biologics, Inc. Eli Lilly and Company Enzolytics Inc. Erytech Pharma Exelixis, Inc. Exosomics Forbion GeminiBio Granite Bio GreenLight Biosciences Grünenthal GSK plc Heat Biologics ImmuneOncia Therapeutics, Inc. Imvaq Therapeutics Innovent Biologics Istari Oncology JSR Life Sciences Junshi Biosciences LAVA Therapeutics N.V. Masterflex Metrics Contract Services Minapharm Pharmaceuticals Moderna Nobelpharma RIM Bio RoosterBio, Inc. Shanghai BravoBio Co., Ltd. Seres Therapeutics Touchlight ValenzaBio Vetter Zhejiang Doer Biologics Co., Ltd.
List of Associations Mentioned in the Report Center for Disease Prevention and Control (CDC) Centre for Drug Evaluation (CDE) European Generic Medicines Association (EGA) European Medicines Agency (EMA) Food and Drug Administration (FDA) Intellectual Property Appellate Board (IPAB) Ministry for Health Labour and Welfare (MHLW) National Health Service (NHS) National Institute for Health and Care Excellence (NICE) Pharmaceuticals and Medical Devices Agency (PMDA) Ministry of Food and Drug Safety (MFDS) UK Medicines and Healthcare Products Regulatory Agency (MHRA) World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Biopharmaceuticals Contract Manufacturing Market Report 2023-2033
The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Single-Use Bioprocessing Probes & Sensors market was valued US$2,493.8 million in 2022 and is projected to grow at a CAGR of 15.2% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
